Barron’s Tepid Review of Amylin Pharmaceuticals (AMLN, PFE, NKTR, SNY, NVO)
-
Font Size:
In Barron’s this past weekend, Bill Alpert discussed the prospects for Amylin Pharmaceuticals (ticker: AMLN). His conclusion: Amylin’s drug, Byetta, “…could emerge as a star in the war against diabetes despite competition and…a possible link to a rare cancer. But all the good news already appears to be in the stock price.
Be the first to comment on this article! See below...
- Myriad Genetics, Inc. F4Q08 (Qtr End 06/30/08) Earnings Call Transcript »
- American Oriental Bioengineering, Inc. Q2 2008 Earnings Call Transcript »
- Would Genentech Be Better Off Left Alone by Roche? »
- Biotech ETFs: Can You Handle 209% Volatility? »
- AstraZeneca Gives FluMist Spray a Shot in the Arm »
Get Seeking Alpha Free Stock Alerts by Email!
Get Free Stock Alerts by Email!
Loading...
Symbols:
ETFs In Focus
sponsored by:
-
Editor's Picks
-
Most Popular
- Disclosure from Financials? I Call B.S.
- Financials and Housing: The Outlook Remains Ugly
- Martin Wolf on Capitalism
- Interview with Jim Rogers, Part I: Bigger Financial Shocks Loom
- Four Brazilian Profit Plays
- Apple & Google: A Detailed Comparison
- Full list of Editor's Picks »
- Apple: Great Company with Lofty Valuation - Due for Pullback »
- Cramer Continues to Dig a Sirius Hole for Himself »
- The Disconnect Between Supply and Demand in Gold & Silver Markets »
- Wall Street Breakfast: Must-Know News »
- The Great Consumer Crash of 2009 »
- With Help from California, Solar Gets Fired Up »
- Don't Cancel Motorola's Funeral Just Yet »
- Forget $100 a Barrel - Oil Will Plummet to $30 »
- Time to Pull the Trigger on Four Oil Service Stocks »
- 5 Potential Buyout Targets in Biotech - Barron's »
- Transocean: An Opportunity in Falling Oil »
-
Long Ideas
-
Short Ideas
-
Cramer's Picks
- Whose Freddie Investment Thesis Is Right?
- Steel Dynamics: Bullish with a Share Repurchase Program
- E-Trade Financial Carries High Risk-Reward
- Interested in Bank of America? Consider the Preferred Shares
- Northgate: Mid-Tier Gold Producer with Strong Cashflow
- Toll Brothers Staying Alive - Fast Money Midday Recap (8/19/08)
- Hedge Fund Tracking: Blue Ridge Capital (John Griffin)
- Petrobras: Buy and Sit Tight Like Soros
- Screener Picks, Part II: Three Mid-cap Growth Stocks
- Lowe’s Weathers a Tough Retail Market
- Full list of Long Ideas »
- Salesforce.com: It's All About the Guidance
- Three Casino Stocks Rolling Over
- New Web Site For Short Sellers: You Gotta Love Capitalism
- Commodity Carnage: Where to Turn Next?
- Fannie and Freddie Shareholders Run for the Exit
- Goldman: Readying Short Position Initiation Sequence
- Apple: Great Company with Lofty Valuation - Due for Pullback
- Russia's Too Risky - Barron's
- Fannie, Freddie Shareholders Will Be Left Holding the Bag - Barron's
- Pilgrim's Pride: The Weakest Link in the Food Chain
- Full list of Short Ideas »
- Clean Energy - Cramer's Lightning Round (8/19/08)
- Still Growing - Cramer's Mad Midday (8/19/08)
- Which Stock to Pick - Cramer's Mad Money (8/18/08)
- Buy Weyerhauser - Cramer's Lightning Round (8/18/08)
- The Price of Oil - Cramer's Mad Money (8/18/08)
- Great Execution Pick - Cramer's Mad Money (8/14/08)
- Beaten Down Buy - Cramer's Lightning Round (8/14/08)
- The Fry Guy - Cramer's Midday Mad Money (8/14/08)
- Go Orbital - Cramer's Mad Money (8/13/08)
- Buy AMD Here - Cramer's Lightning Round (8/13/08)
- Full list of Cramers Picks »
Trading Center
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »